7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 
      
    		                   
      cash flows from operating activities:
    		                   
      net income
    		2,521,000 -228,619,000 -61,986,000 -146,487,000 -12,176,000 -11,737,000 -125,147,000 -21,256,000 3,999,000 -16,895,000 -26,214,000 -29,895,000 -16,110,000 -56,844,000 -18,825,000 -119,271,908 -1,924,883 -1,741,439 -613,770 
      adjustments to reconcile net income to net cash from operating activities:
    		                   
      depreciation and amortization expense
    		4,127,000 3,451,000 3,470,000 3,133,000 3,394,000 2,907,000 2,439,000 1,965,000 1,971,000 1,979,000 1,986,000 1,994,000 2,038,000 1,954,000 1,772,000     
      amortization of debt discount and issuance costs
    		                   
      amortization of discount on htm investments
    		                   
      equity-based compensation expense
    		5,321,000 4,319,000 7,400,000 5,053,000 5,168,000 5,749,000 5,157,000 6,079,000 4,793,000 3,994,000 3,805,000 -295,000 2,222,000 5,080,000 3,858,000     
      goodwill impairment
    		0   0 0 0 85,000,000     18,292,000 0       
      non-cash lease expense
    		1,330,000 254,000 370,000 167,000 190,000 269,000 94,000 147,000 153,000 332,000 -35,000         
      benefit from doubtful accounts
    		0 311,000 40,000 8,000 44,000 5,000 171,000 132,000 50,000 675,000 882,000 0 11,000       
      deferred income tax benefit
    		                   
      loss on extinguishment of debt
    		0 0 2,577,000                 
      increase in fair value of derivatives
    		-26,125,000                   
      changes in assets and liabilities:
    		                   
      decrease (increase) in accounts receivable
    		3,972,000 5,919,000 4,348,000           -1,223,000 1,981,000     
      increase in contract assets
    		          -1,115,000 11,000 -71,000 2,080,000 -2,306,000     
      increase in prepaid expenses and other assets
    		-2,546,000 1,203,000 -1,795,000                 
      decrease in accounts payable
    		2,150,000 -876,000 -4,163,000  -3,177,000               
      increase in accrued expenses
    		1,749,000 319,000 4,446,000                 
      increase in contract liabilities
    		-959,000 1,449,000 476,000 28,000 -983,000 -357,000 1,826,000 -1,441,000   325,000 -2,736,000 1,044,000 -633,000 -1,415,000     
      increase in other liabilities
    		-1,680,000 178,000 1,670,000    551,000 -497,000 -728,000 -1,115,000 49,000 450,000 1,422,000 255,000 83,000     
      net cash from operating activities
    		-9,585,000 -3,868,000 -6,664,000 -14,806,000 -1,896,000 -7,058,000 -14,359,000 -74,000 6,580,000 -12,796,000 -12,017,000 -10,528,000 -6,394,000 -24,467,000 -7,529,000 -17,513,148 -669,383 -521,320 -1,078,149 
      capex
    		-1,330,000 -1,164,000 -1,620,000 -3,414,000 -4,308,000 -1,711,000 -1,681,000 -1,084,000 0 0 0 -33,000 -228,000 -149,000 -359,000 0 0 0 0 
      free cash flows
    		-10,915,000 -5,032,000 -8,284,000 -18,220,000 -6,204,000 -8,769,000 -16,040,000 -1,158,000 6,580,000 -12,796,000 -12,017,000 -10,561,000 -6,622,000 -24,616,000 -7,888,000 -17,513,148 -669,383 -521,320 -1,078,149 
      cash flows from investing activities:
    		                   
      purchases of htm investments
    		                   
      acquisition of business, net of cash acquired
    		   0 0 0 13,935,000             
      purchases of property and equipment
    		-188,000 -5,000 -80,000 -180,000 -137,000 -129,000 -38,000 0 0   -33,000 -228,000 -149,000 -359,000     
      capitalized software development costs
    		-1,142,000 -1,159,000 -1,540,000 -3,234,000 -4,171,000 -1,582,000 -1,643,000 -1,084,000            
      net cash from investing activities
    		-260,069,000 -1,164,000 -1,620,000 -3,414,000 -4,308,000 -1,711,000 12,254,000 -1,084,000 -2,744,000   -33,000 -317,000 -4,525,000 -359,000 357,937,000 0 0 -358,800,000 
      cash flows from financing activities:
    		                   
      proceeds from issuance of shares for exercised rdo and pipe warrants
    		0 0 64,673,000 0 0 0 53,809,000             
      payment of rdo and pipe transaction costs
    		0 0 -551,000                 
      repayment of short-term borrowings
    		-367,000 -85,000 -366,000 0 -417,000 -409,000 -403,000 0 -522,000 -774,000 -763,000 -769,000 -1,152,000 -1,153,000 -1,159,000     
      proceeds from at-the-market offerings
    		                   
      payment of transaction costs for at-the-market offerings
    		                   
      payment of debt issuance costs to third parties
    		0 -337,000 -4,342,000                 
      issuance of common stock upon espp purchase
    		0   760,000 0   645,000            
      proceeds from exercise of options
    		1,971,000 240,000 1,393,000 302,000 0 33,000 86,000             
      payments of tax withholding from the issuance of common stock
    		-358,000 -361,000 -1,318,000 765,000 -3,000 -608,000 -2,532,000             
      net cash from financing activities
    		335,285,000 288,822,000 65,943,000 2,295,000 -420,000 -377,000 50,960,000 1,531,000 -1,575,000 20,894,000 21,212,000 1,238,000 -1,163,000 -1,157,000 -102,055,000 -181,039,101 0 0 361,901,101 
      effect of foreign currency rate changes on cash and cash equivalents
    		104,000 -555,000 -190,000 482,000                
      net increase in cash and cash equivalents
    		65,735,000 283,235,000 57,469,000 -15,443,000 -6,682,000 -9,146,000 48,855,000             
      cash and cash equivalents at the beginning of the period
    		                   
      cash and cash equivalents at the end of the period
    		65,735,000 283,235,000 107,610,000 -15,443,000 -6,682,000 -9,146,000 81,412,000             
      supplemental schedule of non-cash investing and financing activities:
    		                   
      issuance of common stock upon conversion of 2029 notes
    		0 0 135,597,000                 
      issuance of shares for paid-in-kind interest on 2029 convertible notes
    		0                   
      issuance of common stock as consideration for the acquisition of pangiam
    		                   
      amortization of debt issuance costs and discount
    		 2,026,000 2,764,000                 
      decrease in contract assets
    		 -189,000 383,000  -703,000               
      proceeds from at-the-market offering
    		 293,431,000 6,569,000                 
      payment of transaction costs for at-the-market offering
    		 -5,135,000 -115,000                 
      cash and cash equivalents at the beginning of period
    		 0 50,141,000 0 0 0 32,557,000             
      cash paid during the period for:
    		                   
      interest
    		                   
      income taxes
    		                   
      net increase in fair value of derivatives
    		  33,336,000 92,826,000 -1,278,000 -7,882,000 23,992,000   3,121,000 10,567,000         
      proceeds from short-term borrowings
    		                   
      issuance of common stock as consideration for pangiam acquisition
    		    2,987,000 -6,000 207,776,000             
      impairment of right-of-use assets
    		                   
      loss on sale of property and equipment
    		       0 2,000 0 8,000         
      increase in accounts receivable
    		   -6,357,000 836,000    7,189,000 -4,266,000 -3,469,000 1,561,000        
      decrease (increase) in contract assets
    		      2,443,000  -106,000           
      decrease (increase) in prepaid expenses and other assets
    		            3,014,000 103,000 432,000     
      increase in accounts payable
    		       1,962,000 1,778,000 -3,210,000 -4,914,000 7,996,000 1,072,000 -276,000 1,150,000     
      increase in accrued liabilities
    		   -10,483,000 5,958,000 -947,000 2,599,000 602,000 1,375,000 -3,406,000 4,066,000 -4,128,000 1,516,000 -8,816,000 6,307,000     
      proceeds from issuance of private placement and registered direct offering shares
    		                   
      payment of private placement and registered direct offering transaction costs
    		       0 -499,000           
      repurchase of shares as a result of forward share purchase agreements
    		           0 0 0 -100,896,000     
      amortization of debt issuance costs
    		    505,000 506,000 506,000 506,000 506,000 506,000 500,000 732,000 523,000 524,000 523,000     
      deferred income tax (benefit) expense
    		    0 -14,000 -23,000             
      decrease in prepaid expenses and other assets
    		    297,000 293,000 950,000  937,000 3,756,000 1,488,000         
      decrease in other liabilities
    		    29,000               
      (increase) in accounts receivable
    		      -8,957,000             
      (decrease) in accounts payable
    		      -5,960,000             
      proceeds from issuance of private placement shares
    		          21,975,000         
      payment of private placement transaction costs
    		                   
      deferred income tax expense
    		       35,000 0 -1,000 54,000   -1,768,000 174,000     
      acquisition of businesses, net of cash acquired
    		           0 -89,000       
      proceeds from issuance of private placement shares and registered direct offering shares
    		       0 0           
      repayment of term loan
    		                   
      proceeds from issuance of convertible notes
    		                   
      proceeds from the gig business combination
    		                   
      payment of gig business combination transaction costs
    		                   
      payments for taxes related to net share settlement of equity awards
    		       -343,000 -1,085,000   -52,000 -11,000       
      net increase in cash and cash equivalents and restricted cash
    		       373,000 2,261,000 8,096,000 9,195,000 -9,323,000   -109,943,000     
      cash and cash equivalents and restricted cash at the beginning of period
    		       0 0 0 12,632,000 0 0 0 169,921,000     
      cash and cash equivalents and restricted cash at the end of the period
    		       373,000 2,261,000 8,096,000 21,827,000 -9,323,000 -7,874,000 -30,149,000 59,978,000     
      net decrease in fair value of derivatives
    		            -102,000 -199,000 -1,263,000     
      repurchase of shares as a result of forward purchase agreements
    		                   
      issuance of common stock as consideration for the acquisition of promodel corporation
    		            0       
      decrease in contract liabilities
    		                   
      proceeds from disposal of property and equipment
    		                   
      proceeds from term loan
    		                   
      proceeds from promissory notes
    		                   
      repayment of promissory notes
    		                   
      proceeds from the merger
    		                   
      payment of merger transaction costs
    		                   
      distributions to members
    		                   
      parent’s contribution
    		                   
      reconciliation of cash and cash equivalents and restricted cash:
    		                   
      cash and cash equivalents
    		            -7,874,000 -30,149,000 59,978,000     
      restricted cash
    		                   
      cash and cash equivalents and restricted cash at end of the period
    		            -7,874,000 -30,149,000 59,978,000     
      net decrease in cash and cash equivalents and restricted cash
    		                   
      cash and cash equivalents and restricted cash at beginning of year
    		                   
      cash and cash equivalents and restricted cash at end of year
    		                   
      operating activities
    		                   
      change in fair value of warrant liability
    		                -32,989 207,845 22,117 
      interest earned on cash and marketable securities held in trust account
    		                -9,045 -6,194 -4,921 
      change in operating assets and liabilities:
    		                   
      prepaid expenses
    		                20,762   
      receivable from related party
    		                574   
      other long-term assets
    		                79,876   
      accounts payable
    		                -8,122 -16,035 26,553 
      payable to related parties
    		                14,113 22,802 20,454 
      accrued liabilities
    		                1,187,632 761,672 282,745 
      other current liabilities
    		                2,699 1,849 1,468 
      investing activities
    		                   
      investment of cash in trust account
    		                0 0 -358,800,000 
      financing activities
    		                   
      proceeds from sale of units, net of underwriting discounts paid
    		                0 0 351,624,000 
      proceeds from sale of private placement units to founder
    		                0 0 8,500,000 
      proceeds from sale of private placement units to underwriters
    		                0 0 2,496,000 
      repayment of borrowing from a related party
    		                0 0 -125,000 
      payment of offering costs
    		                0 0 -593,899 
      net increase in cash during period
    		                -669,383 -521,320 2,022,952 
      cash, beginning of period
    		                0 0 150,000 
      cash, end of period
    		                -669,383 -521,320 2,172,952 
      supplemental disclosure of non-cash financing activities
    		                   
      offering costs included in accrued liabilities
    		                0 0 70,000 
      fair value of warrant liability
    		                0 0 187,908 
      deferred underwriting fee payable
    		                0 0 12,558,000 
      change in value of common stock subject to possible redemption
    		                16,968,264 -1,741,440 5,185,219 
      common stock subject to possible redemption
    		                   
      numerator: earnings allocable to common stock subject to redemption
    		                   
      interest earned on marketable securities held in trust account, net of taxes
    		                   
      net income attributable to common stock subject to possible redemption
    		                   
      denominator: weighted-average common shares subject to redemption
    		                   
      basic and diluted weighted-average shares outstanding, common stock subject to possible redemption
    		                   
      basic and diluted net income per share, common stock subject to possible redemption
    		                   
      non-redeemable common stock
    		                   
      numerator: net income minus net earnings - basic and diluted
    		                   
      less: net income attributable to common stock subject to redemption
    		                -3,114 -650 -2,582 
      net income attributable to non-redeemable common stock
    		                   
      denominator: weighted-average non-redeemable common shares
    		                   
      weighted-average non-redeemable common shares outstanding, basic and diluted
    		                   
      net income per share
    		                -0.04 -0.09 -0.06 
      net income attributable to common stockholders
    		                 -1,128,319 -616,352 
      weighted-average common shares outstanding, basic and diluted
    		                 1,287,326 10,375,485 
      prepaid and other current assets
    		                  -812,795 
      proceeds from sale of common stock to founder
    		                   
      proceeds from related party loan
    		                   
      deferred offering costs included in accounts payable
    		                   
      deferred offering costs included in accrued liabilities
    		                   
      level 1:
    		                   
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.